Smith Darren Charlton — Group Chief Financial Officer
Insider trading activity for Smith Darren Charlton sourced from SEC EDGAR Form 4 filings.
Overview
- Title: Group Chief Financial Officer
- Company: Telix Pharmaceuticals Ltd
- Total insider trades: 2
- Total buy volume: $0
- Total sell volume: $0
- Last trade: Apr 1, 2026
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Mar 29, 2026 | Smith Darren Charlton | TLX Telix Pharmaceuticals Ltd | OTHER | 1,111 | N/A |
| Mar 29, 2026 | Smith Darren Charlton | TLX Telix Pharmaceuticals Ltd | OTHER | 1,111 | N/A |